Natixis »

Eupraxia Pharmaceuticals shares owned by Natixis

Quarter-by-quarter ownership of Eupraxia Pharmaceuticals (EPRX) shares owned by Natixis from 13F filings

Historical chart of Natixis investment in Eupraxia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eupraxia Pharmaceuticals held by Natixis consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eupraxia Pharmaceuticals by Natixis

Quarter filed Position value Share count Share price at filing
2026-06-30 $115k 18k 6.53

More positions owned by Natixis

Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Micron Technology (MU)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Tesla Motors (TSLA)
Spdr Series Trust St Str P500etf (SPYM)
Energy Transfer Com Ut Ltd Ptn (ET)
Broadcom (AVGO)
Oracle Corporation (ORCL)
JPMorgan Chase & Co. (JPM)

View all positions for Natixis

Top funds holding Eupraxia Pharmaceuticals

Beutel, Goodman & Company
Affinity Asset Advisors
Balyasny Asset Management
Vivo Capital
Scotia Capital
Partner Fund Management
Dr. Jeffrey R. Jay, M.D.
Jupiter Topco
Ikarian Capital
UBS Group
Point72 Asset Management
Rubric Capital Management
Ameriprise Financial
Redmile Group
Citadel Advisors

View all funds holding Eupraxia Pharmaceuticals